Research Article
Formulation and Optimization of Eudragit RS PO-Tenofovir Nanocarriers Using Box-Behnken Experimental Design
Table 2
BBD experimental parameters and levels for preparation of nanoparticles.
| Run | | | | Ratio of a polymer to a drug (mg) | Concentration of a surfactant (% SDS) | Sonication time (min) |
| 1 | 50 | 3 | 45 | 2 | 50 | 5 | 45 | 3 | 100 | 3 | 45 | 4 | 100 | 5 | 45 | 5 | 50 | 4 | 30 | 6 | 50 | 4 | 60 | 7 | 100 | 4 | 30 | 8 | 100 | 4 | 60 | 9 | 75 | 3 | 30 | 10 | 75 | 3 | 60 | 11 | 75 | 5 | 30 | 12 | 75 | 5 | 60 | 13 | 75 | 4 | 45 | 14 | 75 | 4 | 45 | 15 | 75 | 4 | 45 |
|
|